Investing

Top Analyst Upgrades and Downgrades: Best Buy, Dollar General, Intuit, McDonald's, P&G, Symantec, China Telecom and More

Audentes Therapeutics Inc. (NASDAQ: BOLD) was started as Buy with a $23 price objective at Merrill Lynch, noting that the company is well positioned with a focus on gene therapy for rare diseases. Wedbush Securities started it as Outperform with a $20 price target.

Bright Horizons Family Solutions Inc. (NYSE: BFAM) was raised to Overweight from Neutral at JPMorgan.

Equity Commonwealth (NYSE: EQC) was raised to Buy from Neutral with a $33 price objective.

Freshpet Inc. (NASDAQ: FRPT) was downgraded to Neutral from Outperform at Wedbush Securities, but the price target was raised to $11 from $10 (versus a $10.59 close).

Patheon Holdings (NYSE: PTHN) was started as Outperform at William Blair. It was started as Overweight with a $31 price target at Morgan Stanley, and started as Overweight with a $30 price target at JPMorgan. It was started as Outperform with a $32 price target at Robert W. Baird. Piper Jaffray started it as Overweight.

SL Green Realty Corp. (NYSE: SLG) was downgraded to Hold from Buy at Evercore ISI.

There were nine analyst picks under $10 for massive upside in the week of August 12.

Merrill Lynch has 10 equity income picks for its model portfolio with the highest yields.

There are also four top gold stocks analysts want you to buy for 2017.

Friday’s top analyst upgrades and downgrades included Air Products, Akamai, Alibaba, BlackBerry, Consolidated Edison, InvenSense, Under Armour and over a dozen more.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.